Ally Financial Inc. maintained its position in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,000 shares of the company’s stock at the close of the second quarter. Ally Financial Inc.’s holdings in Cardinal Health were worth $1,169,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. lifted its holdings in Cardinal Health by 31.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares in the last quarter. JFS Wealth Advisors LLC lifted its holdings in Cardinal Health by 14.3% during the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares in the last quarter. Dupont Capital Management Corp acquired a new stake in Cardinal Health during the 2nd quarter worth approximately $164,000. First Personal Financial Services lifted its holdings in Cardinal Health by 127.5% during the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares in the last quarter. Finally, Alpha Windward LLC lifted its holdings in Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares in the last quarter. 87.63% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The firm’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 earnings per share.

The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is 45.79%.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/25/ally-financial-inc-continues-to-hold-holdings-in-cardinal-health-inc-cah.html.

CAH has been the topic of a number of analyst reports. Vetr lowered shares of Cardinal Health from a “buy” rating to a “hold” rating and set a $77.92 price objective on the stock. in a report on Thursday, June 1st. Royal Bank Of Canada initiated coverage on shares of Cardinal Health in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $72.00 price objective on the stock. Jefferies Group LLC restated a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a report on Thursday, July 27th. ValuEngine lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Evercore ISI restated an “outperform” rating on shares of Cardinal Health in a report on Tuesday, July 4th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $76.81.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.